Lewis Stanford Seiden - Publications

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Psychopharmacology
Website:
http://www-news.uchicago.edu/releases/07/070730.seiden.shtml

151 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 O'Donnell JM, Marek GJ, Seiden LS. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule. Neuroscience and Biobehavioral Reviews. 29: 785-98. PMID 15893376 DOI: 10.1016/j.neubiorev.2005.03.018  0.687
2003 Overstreet DH, Commissaris RC, De La Garza R, File SE, Knapp DJ, Seiden LS. Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress (Amsterdam, Netherlands). 6: 101-10. PMID 12775329 DOI: 10.1080/1025389031000111311  0.336
2001 Seiden LS, Lew R, Malberg JE. Neurotoxicity of methamphetamine and methylenedioxymethamphetamine. Neurotoxicity Research. 3: 101-16. PMID 15111264 DOI: 10.1007/BF03033233  0.695
2000 Cousins MS, Vosmer G, Overstreet DH, Seiden LS. Rats selectively bred for responsiveness to 5-hydroxytryptamine(1A) receptor stimulation: differences in differential reinforcement of low rate 72-second performance and response to serotonergic drugs. The Journal of Pharmacology and Experimental Therapeutics. 292: 104-13. PMID 10604936  0.349
1999 Sokolowski JD, Seiden LS. The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat. Psychopharmacology. 147: 153-61. PMID 10591882 DOI: 10.1007/S002130051155  0.44
1999 Jolly DC, Richards JB, Seiden LS. Serotonergic mediation of DRL 72s behavior: receptor subtype involvement in a behavioral screen for antidepressant drugs. Biological Psychiatry. 45: 1151-62. PMID 10331107 DOI: 10.1016/S0006-3223(98)00014-6  0.652
1998 Sabol KE, Seiden LS. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis. Brain Research. 806: 69-78. PMID 9739110 DOI: 10.1016/S0006-8993(98)00720-3  0.484
1998 Balcells-Olivero M, Cousins MS, Seiden LS. Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia. The Journal of Pharmacology and Experimental Therapeutics. 286: 742-52. PMID 9694929  0.385
1998 Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 5086-94. PMID 9634574 DOI: 10.1523/Jneurosci.18-13-05086.1998  0.719
1998 Malberg JE, Seiden LS. Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat The Journal of Neuroscience. 18: 5086-5094. DOI: 10.1523/JNEUROSCI.18-13-05086.1998  0.698
1997 Borsini F, Cesana R, Kelly J, Leonard BE, McNamara M, Richards J, Seiden L. BIMT 17: a putative antidepressant with a fast onset of action? Psychopharmacology. 134: 378-86. PMID 9452180 DOI: 10.1007/S002130050474  0.623
1997 Balcells-Olivero M, Richards JB, Seiden LS. Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule. Psychopharmacology. 133: 207-13. PMID 9361325 DOI: 10.1007/S002130050393  0.592
1997 Malberg JE, Seiden LS. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles. Brain Research. 765: 101-7. PMID 9310399 DOI: 10.1016/S0006-8993(97)00517-9  0.742
1997 McCann UD, Seiden LS, Rubin LJ, Ricaurte GA. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. Jama. 278: 666-72. PMID 9272900 DOI: 10.1001/Jama.1997.03550080076043  0.366
1997 Mukherjee J, Yang ZY, Lew R, Brown T, Kronmal S, Cooper MD, Seiden LS. Evaluation of d-amphetamine effects on the binding of dopamine D-2 receptor radioligand, 18F-fallypride in nonhuman primates using positron emission tomography. Synapse (New York, N.Y.). 27: 1-13. PMID 9268060 DOI: 10.1002/(SICI)1098-2396(199709)27:1<1::AID-SYN1>3.0.CO;2-9  0.365
1997 Richards JB, Mitchell SH, de Wit H, Seiden LS. Determination of discount functions in rats with an adjusting-amount procedure. Journal of the Experimental Analysis of Behavior. 67: 353-66. PMID 9163939 DOI: 10.1901/Jeab.1997.67-353  0.546
1997 Lew R, Weisenberg B, Vosmer G, Seiden LS. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields. Synapse (New York, N.Y.). 26: 36-45. PMID 9097403 DOI: 10.1002/(SICI)1098-2396(199705)26:1<36::AID-SYN4>3.0.CO;2-F  0.408
1996 Seiden LS, Sabol KE. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. Nida Research Monograph. 163: 251-76. PMID 8809863  0.303
1996 Malberg JE, Sabol KE, Seiden LS. Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. The Journal of Pharmacology and Experimental Therapeutics. 278: 258-67. PMID 8764359  0.413
1996 Lew R, Sabol KE, Chou C, Vosmer GL, Richards J, Seiden LS. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. The Journal of Pharmacology and Experimental Therapeutics. 276: 855-65. PMID 8632359  0.557
1996 Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations. The Journal of Pharmacology and Experimental Therapeutics. 276: 846-54. PMID 8632358  0.569
1995 Sabol KE, Richards JB, Layton K, Seiden LS. Amphetamine analogs have differential effects on DRL 36-s schedule performance. Psychopharmacology. 121: 57-65. PMID 8539341 DOI: 10.1007/Bf02245591  0.647
1995 Farfel GM, Seiden LS. Role of hypothermia in the mechanism of protection against serotonergic toxicity. II. Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. The Journal of Pharmacology and Experimental Therapeutics. 272: 868-75. PMID 7853205  0.315
1995 Farfel GM, Seiden LS. Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX. The Journal of Pharmacology and Experimental Therapeutics. 272: 860-7. PMID 7531765  0.328
1994 Richards JB, Sabol KE, Hand TH, Jolly DC, Marek GJ, Seiden LS. Buspirone, gepirone, ipsapirone, and zalospirone have distinct effects on the differential-reinforcement-of-low-rate 72-s schedule when compared with 5-HTP and diazepam. Psychopharmacology. 114: 39-46. PMID 7846206 DOI: 10.1007/Bf02245442  0.55
1994 Bergmann BM, Seiden LS, Landis CA, Gilliland MA, Rechtschaffen A. Sleep deprivation in the rat: XVIII. Regional brain levels of monoamines and their metabolites. Sleep. 17: 583-9. PMID 7531362 DOI: 10.1093/Sleep/17.7.583  0.341
1993 Seiden LS, Sabol KE, Ricaurte GA. Amphetamine: effects on catecholamine systems and behavior. Annual Review of Pharmacology and Toxicology. 33: 639-77. PMID 8494354 DOI: 10.1146/annurev.pa.33.040193.003231  0.356
1993 Marek GJ, Heffner TG, Richards JB, Shaughnessy RA, Li AA, Seiden LS. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement. Pharmacology, Biochemistry, and Behavior. 45: 987-90. PMID 8415842 DOI: 10.1016/0091-3057(93)90153-K  0.556
1993 Richards JB, Sabol KE, Seiden LS. DRL interresponse-time distributions: quantification by peak deviation analysis. Journal of the Experimental Analysis of Behavior. 60: 361-85. PMID 8409824 DOI: 10.1901/Jeab.1993.60-361  0.545
1993 Richards JB, Baggott MJ, Sabol KE, Seiden LS. A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time task. Brain Research. 627: 254-60. PMID 8298969 DOI: 10.1016/0006-8993(93)90328-K  0.797
1993 Richards JB, Sabol KE, Seiden LS. Fluoxetine prevents the disruptive effects of fenfluramine on differential-reinforcement-of-low-rate 72-second schedule performance. The Journal of Pharmacology and Experimental Therapeutics. 267: 1256-63. PMID 8263788  0.546
1993 Dunn RT, Richards JB, Seiden LS. Effects of salbutamol upon performance on an operant screen for antidepressants. Psychopharmacology. 113: 1-10. PMID 7862813 DOI: 10.1007/Bf02244325  0.563
1992 Kleven MS, Seiden LS. Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum. Annals of the New York Academy of Sciences. 654: 464-6. PMID 1632605 DOI: 10.1111/J.1749-6632.1992.Tb26000.X  0.454
1992 Sabol KE, Richards JB, Seiden LS. Fenfluramine-induced increases in extracellular hippocampal serotonin are progressively attenuated in vivo during a four-day fenfluramine regimen in rats. Brain Research. 571: 64-72. PMID 1611495 DOI: 10.1016/0006-8993(92)90509-8  0.633
1992 Sabol KE, Richards JB, Seiden LS. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Research. 585: 421-4. PMID 1511330 DOI: 10.1016/0006-8993(92)91249-E  0.594
1992 Sabol KE, Richards JB, Seiden LS. The NMDA receptor antagonist MK-801 does not protect against serotonin depletions caused by high doses of DL-fenfluramine. Brain Research. 582: 129-33. PMID 1386771 DOI: 10.1016/0006-8993(92)90326-5  0.647
1992 Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Research. 578: 235-43. PMID 1380862 DOI: 10.1016/0006-8993(92)90252-5  0.416
1992 Marek GJ, McDougle CJ, Price LH, Seiden LS. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology. 109: 2-11. PMID 1365657 DOI: 10.1007/Bf02245475  0.347
1992 Farfel GM, Vosmer GL, Seiden LS. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine. Brain Research. 595: 121-7. PMID 1361410 DOI: 10.1016/0006-8993(92)91460-V  0.481
1992 SABOL KE, RICHARDS JB, SEIDEN LS. MK801 ENHANCES THE SEROTONIN DEPLETIONS INDUCED BY FENFLURAMINE Behavioural Pharmacology. 3: 66. DOI: 10.1097/00008877-199204001-00205  0.549
1992 RICHARDS JB, SABOL KE, SEIDEN LS. BEHAVIORAL MECHANISM OF THE EFFECTS OF DESIPRAMINE ON THE DRL 72-S ANTIDEPRESSANT SCREEN Behavioural Pharmacology. 3: 50. DOI: 10.1097/00008877-199204001-00153  0.448
1991 Hand TH, Marek GJ, Seiden LS. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity. Psychopharmacology. 105: 453-8. PMID 1771213 DOI: 10.1007/BF02244363  0.406
1991 Kleven MS, Seiden LS. Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum. Brain Research. 557: 340-3. PMID 1747766 DOI: 10.1016/0006-8993(91)90157-Q  0.451
1991 Richards JB, Seiden LS. A quantitative interresponse-time analysis of DRL performance differentiates similar effects of the antidepressant desipramine and the novel anxiolytic gepirone. Journal of the Experimental Analysis of Behavior. 56: 173-92. PMID 1683359 DOI: 10.1901/Jeab.1991.56-173  0.548
1990 Li AA, Marek GJ, Hand TH, Seiden LS. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine. European Journal of Pharmacology. 177: 137-44. PMID 2311675 DOI: 10.1016/0014-2999(90)90263-6  0.386
1990 Kleven MS, Perry BD, Woolverton WL, Seiden LS. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Research. 532: 265-70. PMID 2149299 DOI: 10.1016/0006-8993(90)91768-C  0.391
1990 Marek GJ, Vosmer G, Seiden LS. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat. Brain Research. 516: 1-7. PMID 2142010 DOI: 10.1016/0006-8993(90)90889-J  0.509
1990 Marek GJ, Vosmer G, Seiden LS. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Research. 513: 274-9. PMID 2140952 DOI: 10.1016/0006-8993(90)90467-P  0.472
1990 Axt KJ, Commins DL, Vosmer G, Seiden LS. alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation. Brain Research. 515: 269-76. PMID 2113413 DOI: 10.1016/0006-8993(90)90606-C  0.478
1990 Marek GJ, Vosmer G, Seiden LS. Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats. Pharmacology, Biochemistry, and Behavior. 36: 187-90. PMID 2112259 DOI: 10.1016/0091-3057(90)90147-A  0.511
1990 Pontieri FE, Crane AM, Seiden LS, Kleven MS, Porrino LJ. Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats. Psychopharmacology. 102: 175-82. PMID 1980372 DOI: 10.1007/Bf02245919  0.389
1990 Axt KJ, Seiden LS. alpha-Methyl-p-tyrosine partially attenuates p-chloroamphetamine-induced 5-hydroxytryptamine depletions in the rat brain. Pharmacology, Biochemistry, and Behavior. 35: 995-7. PMID 1971723 DOI: 10.1016/0091-3057(90)90390-4  0.506
1989 Archer T, Beninger RJ, Järbe TU, Seiden LS. Latent learning in a radial arm maze following neonatal dopamine depletion. Behavioural Pharmacology. 1: 191-199. PMID 11224030 DOI: 10.1097/00008877-199000130-00001  0.32
1989 Woolverton WL, Ricaurte GA, Forno LS, Seiden LS. Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Research. 486: 73-8. PMID 2720435 DOI: 10.1016/0006-8993(89)91279-1  0.464
1989 Kleven MS, Seiden LS. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Research. 505: 351-3. PMID 2598057 DOI: 10.1016/0006-8993(89)91467-4  0.496
1989 Li AA, Marek GJ, Vosmer G, Seiden LS. Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats. Pharmacology, Biochemistry, and Behavior. 33: 641-8. PMID 2573905 DOI: 10.1016/0091-3057(89)90402-4  0.557
1989 Commins DL, Shaughnessy RA, Axt KJ, Vosmer G, Seiden LS. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions. Journal of Neural Transmission. 77: 197-210. PMID 2503586 DOI: 10.1007/BF01248932  0.403
1989 Kleven MS, Woolverton WL, Seiden LS. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Research. 488: 121-5. PMID 2472850 DOI: 10.1016/0006-8993(89)90700-2  0.473
1988 Marek GJ, Li A, Seiden LS. Antidepressant-like effects of (+)-oxaprotiline on a behavioral screen. European Journal of Pharmacology. 157: 183-8. PMID 3224637 DOI: 10.1016/0014-2999(88)90381-0  0.386
1988 Marek GJ, Seiden LS. Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behavior. Psychopharmacology. 96: 153-60. PMID 3148140 DOI: 10.1007/BF00177554  0.347
1988 Seiden LS, Kleven MS. Lack of toxic effects of cocaine on dopamine or serotonin neurons in the rat brain. Nida Research Monograph. 88: 276-89. PMID 3145452  0.363
1988 Seiden LS, Commins DL, Vosmer G, Axt K, Marek G. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal fields: a regional analysis in nigrostriatal and mesolimbic projections. Annals of the New York Academy of Sciences. 537: 161-72. PMID 3059922 DOI: 10.1111/J.1749-6632.1988.Tb42104.X  0.428
1988 Nencini P, Woolverton WL, Seiden LS. Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine. Brain Research. 457: 136-42. PMID 2901895 DOI: 10.1016/0006-8993(88)90065-0  0.319
1988 Kleven MS, Woolverton WL, Seiden LS. Lack of long-term monoamine depletions following repeated or continuous exposure to cocaine. Brain Research Bulletin. 21: 233-7. PMID 2461246 DOI: 10.1016/0361-9230(88)90236-5  0.46
1988 Kleven MS, Schuster CR, Seiden LS. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. The Journal of Pharmacology and Experimental Therapeutics. 246: 822-8. PMID 2458447  0.608
1988 Kleven M, Woolverton W, Schuster C, Seiden L. Behavioral and neurochemical effects of repeated or continuous exposure to cocaine. Nida Research Monograph. 81: 86-93. PMID 2457161  0.476
1987 Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. The Journal of Pharmacology and Experimental Therapeutics. 241: 338-45. PMID 2883295  0.643
1987 Commins DL, Axt KJ, Vosmer G, Seiden LS. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine. Brain Research. 419: 253-61. PMID 2445423 DOI: 10.1016/0006-8993(87)90591-9  0.439
1987 Commins DL, Axt KJ, Vosmer G, Seiden LS. 5,6-Dihydroxytryptamine, a serotonergic neurotoxin, is formed endogenously in the rat brain. Brain Research. 403: 7-14. PMID 2435369 DOI: 10.1016/0006-8993(87)90116-8  0.453
1986 Klemfuss H, Seiden LS. Hypothalamic catecholamine metabolism is increased by acute water imbalance. Pharmacology, Biochemistry, and Behavior. 24: 229-35. PMID 3952113 DOI: 10.1016/0091-3057(86)90343-6  0.361
1986 Commins DL, Seiden LS. alpha-Methyltyrosine blocks methylamphetamine-induced degeneration in the rat somatosensory cortex. Brain Research. 365: 15-20. PMID 3947981 DOI: 10.1016/0006-8993(86)90717-1  0.439
1986 Schuster CR, Lewis M, Seiden LS. Fenfluramine: neurotoxicity. Psychopharmacology Bulletin. 22: 148-51. PMID 3726061  0.495
1986 Woolverton WL, Johanson CE, de la Garza R, Ellis S, Seiden LS, Schuster CR. Behavioral and neurochemical evaluation of phenylpropanolamine. The Journal of Pharmacology and Experimental Therapeutics. 237: 926-30. PMID 3712285  0.622
1986 Lucot JB, Seiden LS. Effects of serotonergic agonists and antagonists on the locomotor activity of neonatal rats. Pharmacology, Biochemistry, and Behavior. 24: 537-41. PMID 3486425 DOI: 10.1016/0091-3057(86)90554-X  0.422
1986 Heyman GM, Kinzie DL, Seiden LS. Chlorpromazine and pimozide alter reinforcement efficacy and motor performance. Psychopharmacology. 88: 346-53. PMID 3083455 DOI: 10.1007/BF00180837  0.335
1985 Preston KL, Schuster CR, Seiden LS. Methamphetamine, physostigmine, atropine and mecamylamine: effects on force lever performance. Pharmacology, Biochemistry, and Behavior. 23: 781-8. PMID 4080764 DOI: 10.1016/0091-3057(85)90072-3  0.61
1985 Klemfuss H, Seiden LS. Water deprivation increases anterior hypothalamic norepinephrine metabolism in the rat. Brain Research. 341: 222-7. PMID 4041793 DOI: 10.1016/0006-8993(85)91060-1  0.355
1985 Ricaurte G, Bryan G, Strauss L, Seiden L, Schuster C. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals Science. 229: 986-988. PMID 4023719 DOI: 10.1126/Science.4023719  0.597
1985 Ando K, Johanson CE, Seiden LS, Schuster CR. Sensitivity changes to dopaminergic agents in fine motor control of rhesus monkeys after repeated methamphetamine administration. Pharmacology, Biochemistry, and Behavior. 22: 737-43. PMID 4011634 DOI: 10.1016/0091-3057(85)90522-2  0.64
1985 O'Donnell JM, Seiden LS. Effect of the experimental antidepressant AHR-9377 on performance during differential reinforcement of low response rate. Psychopharmacology. 87: 283-5. PMID 3936083 DOI: 10.1007/BF00432708  0.362
1985 Seiden LS, Pachman SH, Heffner TG, Shaughnessy RA, Vosmer G. The effect of water-deprivation on locomotor activity in rats treated with 6-hydroxydopamine. Brain Research. 337: 225-32. PMID 3928086 DOI: 10.1016/0006-8993(85)90058-7  0.36
1985 Heyman GM, Seiden LS. A parametric description of amphetamine's effect on response rate: changes in reinforcement efficacy and response topography. Psychopharmacology. 85: 154-61. PMID 3925482 DOI: 10.1007/BF00428406  0.364
1985 Kotake C, Heffner T, Vosmer G, Seiden L. Determination of dopamine norepinephrine, serotonin and their major metabolic products in rat brain by reverse-phase ion-pair high performance liquod chromatography with electrochemical detection Pharmacology, Biochemistry and Behavior. 22: 85-89. PMID 2579406 DOI: 10.1016/0091-3057(85)90490-3  0.37
1985 Preston KL, Wagner GC, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on monoamine neurons in the rhesus monkey brain. Brain Research. 338: 243-8. PMID 2411342 DOI: 10.1016/0006-8993(85)90153-2  0.746
1984 Ricaurte GA, Seiden LS, Schuster CR. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Research. 303: 359-64. PMID 6744029 DOI: 10.1016/0006-8993(84)91221-6  0.575
1984 Preston KL, Wagner GC, Seiden LS, Schuster CR. Effects of methamphetamine on atropine-induced conditioned gustatory avoidance. Pharmacology, Biochemistry, and Behavior. 20: 601-7. PMID 6728875 DOI: 10.1016/0091-3057(84)90310-1  0.725
1984 Ricaurte GA, Guillery RW, Seiden LS, Schuster CR. Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion. Brain Research. 291: 378-82. PMID 6697198 DOI: 10.1016/0006-8993(84)91273-3  0.615
1984 Seiden LS, Vosmer G. Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine. Pharmacology, Biochemistry, and Behavior. 21: 29-31. PMID 6431452 DOI: 10.1016/0091-3057(84)90125-4  0.509
1984 O'Donnell JM, Seiden LS. Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine. The Journal of Pharmacology and Experimental Therapeutics. 229: 629-35. PMID 6427446  0.331
1984 Heffner TG, Vosmer G, Seiden LS. Time-dependent changes in hypothalamic dopamine metabolism during feeding in the rat. Pharmacology, Biochemistry, and Behavior. 20: 947-9. PMID 6205405 DOI: 10.1016/0091-3057(84)90021-2  0.38
1984 Heffner TG, Vosmer G, Seiden LS. Increased transport of 3,4-dihydroxyphenylacetic acid from brain during performance of operant behavior in the rat. Brain Research. 293: 85-91. PMID 6200185 DOI: 10.1016/0006-8993(84)91455-0  0.448
1983 Wagner GC, Lucot JB, Schuster CR, Seiden LS. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Research. 270: 285-8. PMID 6883096 DOI: 10.1016/0006-8993(83)90602-9  0.756
1983 Ricaurte GA, Seiden LS, Schuster CR. Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology. 22: 1383-8. PMID 6664467 DOI: 10.1016/0028-3908(83)90228-9  0.592
1983 Ricaurte GA, Fuller RW, Perry KW, Seiden LS, Schuster CR. Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine. Neuropharmacology. 22: 1165-9. PMID 6606137 DOI: 10.1016/0028-3908(83)90075-8  0.631
1983 Heffner TG, Heller A, Miller FE, Kotake C, Seiden LS. Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons. Brain Research. 285: 29-37. PMID 6411289 DOI: 10.1016/0165-3806(83)90105-0  0.476
1983 Heffner TG, Seiden LS. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life. Psychopharmacology. 79: 115-9. PMID 6405418 DOI: 10.1007/Bf00427796  0.496
1982 Wagner GC, Preston K, Ricaurte GA, Schuster CR, Seiden LS. Neurochemical similarities between d,l-cathinone and d-amphetamine. Drug and Alcohol Dependence. 9: 279-84. PMID 7128450 DOI: 10.1016/0376-8716(82)90067-9  0.707
1982 Lucot JB, Seiden LS. The effects of intracerebroventricular administration of 5,6-dihydroxytryptamine to neonatal rats. Brain Research. 247: 177-80. PMID 7127117 DOI: 10.1016/0006-8993(82)91046-0  0.473
1982 O'Donnell JM, Seiden LS. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology. 78: 214-8. PMID 6818577 DOI: 10.1007/BF00428153  0.366
1982 Lucot JB, Wagner GC, Schuster CR, Seiden LS. Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine. Brain Research. 247: 181-3. PMID 6812856 DOI: 10.1016/0006-8993(82)91047-2  0.749
1982 O'Donnell JM, Rider DP, Somani S, Seiden LS. The effect of repeated desipramine administration on water intake in rats. Psychopharmacology. 77: 129-33. PMID 6812130 DOI: 10.1007/BF00431934  0.42
1982 Lucot JB, Seiden LS. Effects of neonatal administration of 5,7-dihydroxytryptamine on locomotor activity. Psychopharmacology. 77: 114-6. PMID 6812128 DOI: 10.1007/Bf00431931  0.417
1982 Finnegan KT, Ricaurte G, Seiden LS, Schuster CR. Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacology. 77: 43-52. PMID 6812118 DOI: 10.1007/BF00436098  0.584
1982 Heffner TG, Seiden LS. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine. Brain Research. 244: 81-90. PMID 6288184 DOI: 10.1016/0006-8993(82)90906-4  0.545
1982 Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Research. 235: 93-103. PMID 6145488 DOI: 10.1016/0006-8993(82)90198-6  0.614
1982 Miller FE, Seiden LS. Locomotor hyperactivity following chronic alpha-methyltyrosine administration in the neonatal rat. Brain Research. 282: 91-2. PMID 6130827 DOI: 10.1016/0165-3806(82)90178-X  0.347
1981 Luttinger D, Seiden LS. Increased hypothalamic norepinephrine metabolism after water deprivation in the rat. Brain Research. 208: 147-65. PMID 7470917 DOI: 10.1016/0006-8993(81)90627-2  0.318
1981 Wagner GC, Foltin RW, Seiden LS, Schuster CR. Dopamine depletion by 6-hydroxydopamine prevents conditioned taste aversion induced by methylamphetamine but not lithium chloride. Pharmacology, Biochemistry, and Behavior. 14: 85-8. PMID 7465611 DOI: 10.1016/0091-3057(81)90107-6  0.713
1981 Heffner TG, Luttinger D, Hartman JA, Seiden LS. Regional changes in brain catecholamine turnover in the rat during performance on fixed ratio and variable interval schedules of reinforcement. Brain Research. 214: 215-8. PMID 7237162 DOI: 10.1016/0006-8993(81)90458-3  0.398
1981 Bittner SE, Wagner GC, Aigner TG, Seiden LS. Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacology, Biochemistry, and Behavior. 14: 481-6. PMID 6940202 DOI: 10.1016/0091-3057(81)90306-3  0.654
1981 Miller FE, Heffner TG, Kotake C, Seiden LS. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Brain Research. 229: 123-32. PMID 6796194 DOI: 10.1016/0006-8993(81)90750-2  0.499
1981 Wagner GC, Lucot JB, Schuster CR, Seiden LS. The ontogeny of aggregation-enhanced toxicity. Psychopharmacology. 75: 92-3. PMID 6795666 DOI: 10.1007/BF00433509  0.699
1981 Wagner GC, Schuster CR, Seiden LS. Neurochemical consequences following administration of CNS stimulants to the neonatal rat. Pharmacology, Biochemistry, and Behavior. 14: 117-9. PMID 6110209 DOI: 10.1016/0091-3057(81)90113-1  0.759
1980 McGuire PS, Seiden LS. Differential effects of imipramine in rats as a function of DRL schedule value. Pharmacology, Biochemistry, and Behavior. 13: 691-4. PMID 7443738 DOI: 10.1016/0091-3057(80)90013-1  0.405
1980 Heffner TG, Hartman JA, Seiden LS. A rapid method for the regional dissection of the rat brain. Pharmacology, Biochemistry, and Behavior. 13: 453-6. PMID 7422701 DOI: 10.1016/0091-3057(80)90254-3  0.351
1980 Lucot JB, Wagner GC, Schuster CR, Seiden LS. The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine. Pharmacology, Biochemistry, and Behavior. 13: 409-13. PMID 7422696 DOI: 10.1016/0091-3057(80)90247-6  0.742
1980 Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Research. 193: 153-63. PMID 7378814 DOI: 10.1016/0006-8993(80)90952-X  0.657
1980 Heffner TG, Hartman JA, Seiden LS. Feeding increases dopamine metabolism in the rat brain. Science (New York, N.Y.). 208: 1168-70. PMID 7375926 DOI: 10.1126/Science.7375926  0.445
1980 Levine TE, McGuire PS, Heffner TG, Seiden LS. DRL performance in 6-hydroxydopamine-treated rats. Pharmacology, Biochemistry, and Behavior. 12: 287-91. PMID 7375491 DOI: 10.1016/0091-3057(80)90370-6  0.498
1980 Levine TE, Erinoff L, Dregits DP, Seiden LS. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior. Pharmacology, Biochemistry, and Behavior. 12: 281-5. PMID 7375490 DOI: 10.1016/0091-3057(80)90369-X  0.441
1980 Heffner TG, Seiden LS. Synthesis of catecholamines from [3H]tyrosine in brain during the performance of operant behavior. Brain Research. 183: 403-19. PMID 7353146 DOI: 10.1016/0006-8993(80)90475-8  0.418
1980 Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Research. 181: 151-60. PMID 7350950 DOI: 10.1016/0006-8993(80)91265-2  0.816
1980 Wagner GC, Ricaurte GA, Johanson CE, Schuster CR, Seiden LS. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology. 30: 547-50. PMID 6768005 DOI: 10.1212/Wnl.30.5.547  0.65
1979 Heffner TG, Seiden LS. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats. The Journal of Pharmacology and Experimental Therapeutics. 208: 134-43. PMID 759608  0.426
1979 Seiden LS, Andresen J, MacPhail RC. Methylphenidate and d-amphetamine: effects and interactions with alphamethyltyrosine and tetrabenazine on DRL performance in rats. Pharmacology, Biochemistry, and Behavior. 10: 577-84. PMID 572553 DOI: 10.1016/0091-3057(79)90236-3  0.432
1979 Wagner GC, Seiden LS, Schuster CR. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug and Alcohol Dependence. 4: 435-8. PMID 510182 DOI: 10.1016/0376-8716(79)90076-0  0.752
1979 Pearl RG, Seiden LS. d-Amphetamine-induced increase in catecholamine synthesis in the corpus striatum of the rat: persistence of the effect after tolerance. Journal of Neural Transmission. 44: 21-38. PMID 438802  0.348
1979 Erinoff L, MacPhail RC, Heller A, Seiden LS. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat. Brain Research. 164: 195-205. PMID 427556 DOI: 10.1016/0006-8993(79)90015-5  0.412
1979 Johanson CE, Aigner TG, Seiden LS, Schuster CR. The effects of methamphetamine on fine motor control in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 11: 273-8. PMID 116246 DOI: 10.1016/0091-3057(79)90134-5  0.559
1979 Wagner GC, Aigner TG, Seiden LS, Schuster CR. Long-term dopamine depletions and behavioral consequences following treatment with methamphetamine Federation Proceedings. 38: No.3312.  0.54
1979 Heffner TG, Hartman JA, Seiden LS. Changes in brain dopamine (DA) metabolism during feeding in the rat Federation Proceedings. 38: No. 766.  0.348
1978 Johanson CE, Schuster CR, Aigner T, Seiden LS. Effects of methamphetamine and haloperidol on fine motor control before and after repeated injections of methamphetamine Federation Proceedings. 37: No.329.  0.468
1977 Albert LH, Emmett-Oglesby M, Seiden LS. Effects of schedules of reinforcement on brain catecholamine metabolism in the rat. Pharmacology, Biochemistry, and Behavior. 6: 481-6. PMID 896886 DOI: 10.1016/0091-3057(77)90105-8  0.333
1976 MacPhail RC, Seiden LS. Effects of intermittent and repeated administration of d-amphetamine on restricted water intake in rats. The Journal of Pharmacology and Experimental Therapeutics. 197: 303-10. PMID 1271282  0.316
1976 Pearl RG, Seiden LS. The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat. The Journal of Pharmacology and Experimental Therapeutics. 198: 635-47. PMID 978464  0.33
1976 Seiden LS, Fischman MW, Schuster CR. Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug and Alcohol Dependence. 1: 215-9. PMID 828106 DOI: 10.1016/0376-8716(76)90030-2  0.559
1975 Macphail RC, Seiden LS. Time course for the effects of cocaine on fixed-ratio water-reinforced responding in rats. Psychopharmacologia. 44: 1-4. PMID 1197574 DOI: 10.1007/BF00421174  0.427
1974 Campbell AB, Seiden LS. The effect of relative and absolute reinforcement magnitude on operant responding. Physiology & Behavior. 12: 843-9. PMID 4837423 DOI: 10.1016/0031-9384(74)90022-5  0.322
1973 Campbell JC, Seiden LS. Performance influence on the development of tolerance to amphetamine. Pharmacology, Biochemistry, and Behavior. 1: 703-8. PMID 4785808 DOI: 10.1016/0091-3057(73)90034-8  0.501
1973 Boggan WO, Seiden LS. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. Physiology & Behavior. 10: 9-12. PMID 4540511 DOI: 10.1016/0031-9384(73)90077-2  0.365
1972 Lewy AJ, Seiden LS. Operant behavior changes norepinephrine metabolism in rat brain. Science (New York, N.Y.). 175: 454-6. PMID 5007913 DOI: 10.1126/Science.175.4020.454  0.362
1971 Seiden LS, Martin TW. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase. Physiology & Behavior. 6: 453-8. PMID 5148757 DOI: 10.1016/0031-9384(71)90182-X  0.405
1971 Boggan WO, Seiden LS. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. Physiology & Behavior. 6: 215-7. PMID 5125476 DOI: 10.1016/0031-9384(71)90028-X  0.371
1971 Campbell AB, Brown RM, Seiden LS. A selective effect of p-chlorophenylalanine on fixed-ratio responding. Physiology & Behavior. 7: 853-7. PMID 4257313 DOI: 10.1016/0031-9384(71)90051-5  0.374
1966 Killam KF, Killam EK, Seiden LS. The interaction of injected reserpine and dihydroxyphenylalanine or D-amphetamine on electrophysiological and behavioral responses in a conditioned approach situation in the cat. Shinkei Kenkyå« No Shimpo. Advances in Neurological Sciences. 10: 305-6. PMID 6010310  0.575
1966 Heller A, Seiden LS, Moore RY. Regional effects of lateral hypothalamic lesions on brain norepinephrine in the cat. International Journal of Neuropharmacology. 5: 91-101. PMID 5913742 DOI: 10.1016/0028-3908(66)90054-2  0.307
1965 HELLER A, SEIDEN LS, PORCHER W, MOORE RY. 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN RAT BRAIN: EFFECT OF HYPOTHALAMIC LESIONS. Science (New York, N.Y.). 147: 887-8. PMID 14245772 DOI: 10.1126/Science.147.3660.887  0.401
1964 SEIDEN LS, CARLSSON A. BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 5: 178-81. PMID 14138753 DOI: 10.1007/BF00413240  0.497
1964 Seiden LS, Hanson LC. Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA. Psychopharmacologia. 6: 239-44. PMID 5830803 DOI: 10.1007/BF00413153  0.406
1963 SEIDEN LS, CARLSSON A. TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 4: 418-23. PMID 14048562 DOI: 10.1007/BF00403346  0.522
1962 SEIDEN LS, WESTLEY J. Partial purification of monoamine oxidase from rat brain. Biochimica Et Biophysica Acta. 58: 363-4. PMID 13910292 DOI: 10.1016/0006-3002(62)91026-0  0.711
Show low-probability matches.